Jump Financial, LLC Cyma Bay Therapeutics, Inc. Transaction History

Jump Financial, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 21, 2024	BUY	$10.86 - $17.62 $691,608 - $1.12 Million	63,684 New	63,684 $949,000
Q3 2023 Nov 07, 2023	BUY	$10.86 - $17.62 $691,608 - $1.12 Million	63,684 New	63,684 $949,000
Q4 2022 Feb 13, 2023	BUY	$3.22 - $6.27 $227,979 - $443,922	70,801 New	70,801 $443,000
Q2 2021 Aug 13, 2021	SELL	$3.94 - $4.92 $160,358 - $200,244	-40,700 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$4.23 - $6.55 $84,557 - $130,934	-19,990 Reduced 32.94%	40,700 $185,000
Q4 2020 Feb 12, 2021	BUY	$5.73 - $9.03 $347,753 - $548,030	60,690 New	60,690 $348,000

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.